A protein-based Covid-19 vaccine that completely blocks the transmission of the virus to non-immune individuals has been developed by an Australian company, Vaxine Pty Ltd.
The COVAX-19™ vaccine is said to be a game-changer in the battle against the pandemic which would allow to lier re-opening of national borders after it was shown to not only protect but also to completely block virus transmission to non-immune animals.
The world has been begging for a highly effective and safe Covid-19 vaccine that blocks the pandemic transmission cycle. Vaxine has now delivered this.”
-Sharen Pringle, Business Manager, Vaxine